Conversely, genetically predicted higher levels expression of ARNTL, CAMKK2, CTSB, FADS2, KDM5A, MEG3, SREBF1 and STAT3 were inversely associated with T2D risk. This evidence concerns the gene SREBF1 and type 2 diabetes mellitus.